WIN-Partners Co., Ltd.

Yield per half year: -1.41%
Dividend yield: 3.82%
Sector: Healthcare

WIN-Partners Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
18.82 149.2 -87.38% 17.77 +5.9%
P/S 0.4668 86.18 -99.46%
P/BV 1.58 74.47 -97.88%
P/FCF 23.83 47.64 -49.98%
Ev/Ebitda 7.03 101.64 -93.08%
Ev/S 0.2674 84.24 -99.68%
Ev/FCF 13.65 -66.76 -120.44%
E/P 0.0531 0.0262 102.74%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
3.8 -190.28 -102% 4 -5.02%
ROE 8.39 -9.77 -185.89%
ROA 4.33 0.7046 514.69%
ROIC 0 8 -100%
ROS 2.48 -225.69 -101.1%
ROCE 11.9 -7.48 -259.18%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 6.69 -100% 0 0%
Nеt Debt/Ebitda -5.24 -56.44 -90.72%
Debt/Ratio 0 0.1494 -100%
Debt/Equity 0.9369 1.1 -14.62%
Debt/Net Income 0 6.07 -100%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
9.55/10
3.82 1.79 112.82% 5.13 -25.5%
Number of years of dividend growth 6 1.76 241.86%
DSI 1 0.717 39.46%
Average dividend growth 7.11 -106.57 -106.67%
Average percentage for 5 years 5.13 17.41 -70.54%
Average percentage for payments 52.11 43.79 19.02%
Difference from average difference in sector 2.03

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
31.05 206.62 -84.97%
Growth impulse Ebitda in 5 years 25.35 378.35 -93.3%
Growth impulse Net Income in 5 years 31.11 262.82 -88.16%
Growth impulse FCF in 5 years 136.67 291.18 -53.06%
Growth impulse EPS in 5 years 31.28 121.69 -74.3%
IP Score
7.06/10

Similar companies

Daiichi Sankyo Company, Limited

HOYA Corporation

Olympus Corporation

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription